CA Patent
CA2985379A1 — Micronized pharmaceutical compositions for treatment of angiogenisis conditions
Assigned to Hutchmed Ltd · Expires 2016-12-01 · 9y expired
What this patent protects
The present disclosure provides pharmaceutical compositions comprising micronized Compound A and use thereof.
USPTO Abstract
The present disclosure provides pharmaceutical compositions comprising micronized Compound A and use thereof.
Drugs covered by this patent
- Invega Sustenna (PALIPERIDONE PALMITATE) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.